Conference Call to Discuss Positive Results from Phase 1 Study of Aritinercept (AUR200)
Aurinia Pharmaceuticals Inc. (AUPH)
Conference
Call date: 2025-06-30
Concluded
Aurinia Pharmaceuticals Inc. (AUPH)